Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nai-Kong V Cheung

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Antibody-based targeted radiation to pediatric tumorsShakeel Modak, Nai-Kong V Cheung
International Journal of Cancer|December 18, 2008
Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugsJian Hu, Nai-Kong V Cheung
Seminars in Oncology|December 3, 2014
GD2-targeted immunotherapy and radioimmunotherapyKonstantin Dobrenkov, Nai-Kong V Cheung
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastomaNai-Kong V Cheung, Shakeel Modak
FEBS Letters|December 4, 2013
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapyMahiuddin Ahmed, Nai-Kong V Cheung
Expert Opinion on Therapeutic Targets|January 22, 2015
Disialoganglioside GD2 as a therapeutic target for human diseasesMaya Suzuki, Nai-Kong V Cheung
Cancer Treatment Reviews|March 16, 2010
Neuroblastoma: Therapeutic strategies for a clinical enigmaShakeel Modak, Nai-Kong V Cheung
Cancer Investigation|March 17, 2007
Disialoganglioside directed immunotherapy of neuroblastomaShakeel Modak, Nai-Kong V Cheung
Expert Opinion on Biological Therapy|February 17, 2009
Monoclonal antibody therapies for solid tumorsDimiter V Tassev, Nai-Kong V Cheung
Cancer Treatment Reviews|June 17, 2017
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignanciesJeong A Park, Nai-Kong V Cheung
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Antibody-based targeted radiation to pediatric tumorsShakeel Modak, Nai-Kong V Cheung
International Journal of Cancer|December 18, 2008
Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugsJian Hu, Nai-Kong V Cheung
Seminars in Oncology|December 3, 2014
GD2-targeted immunotherapy and radioimmunotherapyKonstantin Dobrenkov, Nai-Kong V Cheung
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastomaNai-Kong V Cheung, Shakeel Modak
FEBS Letters|December 4, 2013
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapyMahiuddin Ahmed, Nai-Kong V Cheung
Expert Opinion on Therapeutic Targets|January 22, 2015
Disialoganglioside GD2 as a therapeutic target for human diseasesMaya Suzuki, Nai-Kong V Cheung
Cancer Treatment Reviews|March 16, 2010
Neuroblastoma: Therapeutic strategies for a clinical enigmaShakeel Modak, Nai-Kong V Cheung
Cancer Investigation|March 17, 2007
Disialoganglioside directed immunotherapy of neuroblastomaShakeel Modak, Nai-Kong V Cheung
Expert Opinion on Biological Therapy|February 17, 2009
Monoclonal antibody therapies for solid tumorsDimiter V Tassev, Nai-Kong V Cheung
Cancer Treatment Reviews|June 17, 2017
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignanciesJeong A Park, Nai-Kong V Cheung
Pageof 24